These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 9973244)
1. Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms. Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC Crit Rev Oncog; 1998; 9(2):99-106. PubMed ID: 9973244 [TBL] [Abstract][Full Text] [Related]
2. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC Semin Oncol; 1998 Apr; 25(2 Suppl 6):45-52. PubMed ID: 9625383 [TBL] [Abstract][Full Text] [Related]
3. Cachexia and anorexia. Mantovani G Support Care Cancer; 2000 Nov; 8(6):506-9. PubMed ID: 11094998 [No Abstract] [Full Text] [Related]
4. Megestrol acetate for the treatment of anorexia-cachexia syndrome. Berenstein EG; Ortiz Z Cochrane Database Syst Rev; 2005 Apr; (2):CD004310. PubMed ID: 15846706 [TBL] [Abstract][Full Text] [Related]
7. Treatment of the cancer anorexia-cachexia syndrome: a critical reappraisal. Lelli G; Montanari M; Gilli G; Scapoli D; Antonietti C; Scapoli D J Chemother; 2003 Jun; 15(3):220-5. PubMed ID: 12868546 [TBL] [Abstract][Full Text] [Related]
8. Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients. Mantovani G; Macciò A; Esu S; Lai P; Santona MC; Massa E; Dessì D; Melis GB; Del Giacco GS Eur J Cancer; 1997 Apr; 33(4):602-7. PubMed ID: 9274442 [TBL] [Abstract][Full Text] [Related]
9. Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide. Wen HS; Li X; Cao YZ; Zhang CC; Yang F; Shi YM; Peng LM Chemotherapy; 2012; 58(6):461-7. PubMed ID: 23406994 [TBL] [Abstract][Full Text] [Related]
10. Megestrol acetate in neoplastic anorexia/cachexia: clinical evaluation and comparison with cytokine levels in patients with head and neck carcinoma treated with neoadjuvant chemotherapy. Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Santona MC; Del Giacco GS Int J Clin Lab Res; 1995; 25(3):135-41. PubMed ID: 8562975 [TBL] [Abstract][Full Text] [Related]
11. Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers. Kouchaki B; Janbabai G; Alipour A; Ala S; Borhani S; Salehifar E Support Care Cancer; 2018 Jul; 26(7):2479-2489. PubMed ID: 29442239 [TBL] [Abstract][Full Text] [Related]
12. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (review). Strang P Anticancer Res; 1997; 17(1B):657-62. PubMed ID: 9066597 [TBL] [Abstract][Full Text] [Related]
13. Medroxyprogesterone acetate and megestrol acetate reduce cisplatin-induced serotonin release from human peripheral blood mononuclear cells of cancer patients. Mantovani G; Macciò A; Lai P; Esu S; Massa E; Santona MC; Massa D; Dessì D; Ghiani M Oncol Rep; 1998; 5(1):121-4. PubMed ID: 9458305 [TBL] [Abstract][Full Text] [Related]
14. Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly. Yeh SS; Lovitt S; Schuster MW J Nutr Health Aging; 2009 May; 13(5):448-54. PubMed ID: 19390752 [TBL] [Abstract][Full Text] [Related]
15. Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia. Vadell C; Seguí MA; Giménez-Arnau JM; Morales S; Cirera L; Bestit I; Batiste E; Blanco R; Jolis L; Boleda M; Antón I Am J Clin Oncol; 1998 Aug; 21(4):347-51. PubMed ID: 9708631 [TBL] [Abstract][Full Text] [Related]
16. [Croatian guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome]. Krznarić Z; Juretić A; Samija M; Dintinjana RD; Vrdoljak E; Samarzija M; Kolacek S; Vrbanec D; Prgomet D; Ivkić M; Zelić M; Lijec Vjesn; 2007 Dec; 129(12):381-6. PubMed ID: 18383739 [TBL] [Abstract][Full Text] [Related]
17. Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome--a systematic review and meta-analysis. Leśniak W; Bała M; Jaeschke R; Krzakowski M Pol Arch Med Wewn; 2008 Nov; 118(11):636-44. PubMed ID: 19140567 [TBL] [Abstract][Full Text] [Related]
19. Mirtazapine versus megestrol acetate in treatment of anorexia-cachexia in advanced cancer patients: a randomized, double-blind trial. Chowdhury IH; Rahman MS; Chowdhury MNK; Afroze YJ; Tabassum M; Marnush M; Zerin N Jpn J Clin Oncol; 2024 May; 54(5):530-536. PubMed ID: 38323684 [TBL] [Abstract][Full Text] [Related]
20. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer. Gebbia V; Testa A; Gebbia N Br J Cancer; 1996 Jun; 73(12):1576-80. PubMed ID: 8664133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]